Lion (Spiden)
Spiden provides and develops products that enable real-time and continuous monitoring of blood biomarkers.
Lion (Spiden) has raised €38M across 2 funding rounds from 9 investors, most recently a Series A round in Dec 2024. Based in Freienbach, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Freienbach, Switzerlandwww.spiden.com ↗
Total raised
€38M
€38,467,721
Funding rounds
2
Investors
9
distinct backers
Active since
2021-04
latest 2024-12
Funding by year
EUR raised per yearLion (Spiden) — funding by year — interactive chart.
Data table
| Lion (Spiden) — funding by year | |
|---|---|
| 2021 | €15M |
| 2024 | €24M |
Signals
Medium confidenceRaise-next likelihood68
base rate 44% for Series A
- ▲ In typical raise window
- ▲ Up-round momentum
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-06 | Series A | €24M | — | View deal → |
| 2021-04-29 | Other | €15M | btov Partners,Business Angels,Daniel Gutenberg,Edward Ludwig,Geberit,Kirill Evstratov+3 more | View deal → |
Investors
9Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData